254 related articles for article (PubMed ID: 18575768)
21. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors.
Mitra SK; Mikolon D; Molina JE; Hsia DA; Hanson DA; Chi A; Lim ST; Bernard-Trifilo JA; Ilic D; Stupack DG; Cheresh DA; Schlaepfer DD
Oncogene; 2006 Sep; 25(44):5969-84. PubMed ID: 16682956
[TBL] [Abstract][Full Text] [Related]
22. Targeting of FAK Ser910 by ERK5 and PP1delta in non-stimulated and phorbol ester-stimulated cells.
Villa-Moruzzi E
Biochem J; 2007 Nov; 408(1):7-18. PubMed ID: 17692050
[TBL] [Abstract][Full Text] [Related]
23. Focal adhesion kinase: a potential target in cancer therapy.
van Nimwegen MJ; van de Water B
Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
[TBL] [Abstract][Full Text] [Related]
24. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
25. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
[TBL] [Abstract][Full Text] [Related]
26. Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer.
Hao HF; Takaoka M; Bao XH; Wang ZG; Tomono Y; Sakurama K; Ohara T; Fukazawa T; Yamatsuji T; Fujiwara T; Naomoto Y
Biochem Biophys Res Commun; 2012 Jul; 423(4):744-9. PubMed ID: 22705303
[TBL] [Abstract][Full Text] [Related]
27. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
28. [The influence of down-regulation of focal adhesion kinase by RNA interference on the adhesion and migration of rat hepatic stellate cells in vitro].
An JY; Zhang XL; Yao DM; Dun ZN; Xie SR; Hao LS
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):509-14. PubMed ID: 19912685
[TBL] [Abstract][Full Text] [Related]
29. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
Park H; Han I; Kwon HJ; Oh ES
Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F
Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
32. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
33. Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor.
Andersson S; D'Arcy P; Larsson O; Sehat B
Biochem Biophys Res Commun; 2009 Sep; 387(1):36-41. PubMed ID: 19545541
[TBL] [Abstract][Full Text] [Related]
34. Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma.
Masuda T; Wada K; Nakajima A; Okura M; Kudo C; Kadowaki T; Kogo M; Kamisaki Y
Clin Cancer Res; 2005 Jun; 11(11):4012-21. PubMed ID: 15930335
[TBL] [Abstract][Full Text] [Related]
35. FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration.
Jacamo R; Jiang X; Lunn JA; Rozengurt E
J Cell Physiol; 2007 Feb; 210(2):436-44. PubMed ID: 17096371
[TBL] [Abstract][Full Text] [Related]
36. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma.
Kusayama M; Wada K; Nagata M; Ishimoto S; Takahashi H; Yoneda M; Nakajima A; Okura M; Kogo M; Kamisaki Y
Cancer Sci; 2011 Jun; 102(6):1128-36. PubMed ID: 21401805
[TBL] [Abstract][Full Text] [Related]
37. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
[TBL] [Abstract][Full Text] [Related]
38. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
39. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE
J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669
[TBL] [Abstract][Full Text] [Related]
40. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
